Clinical Trials Logo

Post Partum Hemorrhage clinical trials

View clinical trials related to Post Partum Hemorrhage.

Filter by:

NCT ID: NCT04117243 Recruiting - Clinical trials for Post Partum Hemorrhage

Tranexamic Acid Versus Sublingual Misoprostol in Reducing Blood Loss During Elective CS in High Risk Cases

Start date: January 20, 2020
Phase: Phase 2
Study type: Interventional

The Efficacy and safety of Preoperative Intravenous Tranexamic acid versus Sublingual misoprostol in reducing blood loss during and after Elective Cesarean section among high risk pregnant cases.

NCT ID: NCT02410759 Recruiting - Clinical trials for Post Partum Hemorrhage

Carbetocin Versus Ergometrine in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally

Start date: April 2015
Phase: Phase 3
Study type: Interventional

200 women will be randomly divided into 2 equal groups using computer generated random numbers. Group 1 will receive Carbetocin 100 µgm (Pabal® Ferring, UK) and group 2 will receive ergometrine 0.5mg (methergin®, Novartis, Switzerland).

NCT ID: NCT02306733 Recruiting - Clinical trials for Post Partum Hemorrhage

Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally

Start date: November 2014
Phase: Phase 3
Study type: Interventional

200 women with PPH will be randomly divided into 2 equal groups using computer generated random numbers. Group 1 will receive Ergometrine 400µgm (Methergin® Novartis, Switzerland) and group 2 will receive oxytocin 10 IU (Syntocinon®, Novartis, Switzerland). The investigators will not include a control group for ethical reasons.